28.11.2014 Views

Ultrasound Imaging in Multifetal Pregnancies: Its

Ultrasound Imaging in Multifetal Pregnancies: Its

Ultrasound Imaging in Multifetal Pregnancies: Its

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

“<strong>Ultrasound</strong> <strong>Imag<strong>in</strong>g</strong> <strong>in</strong><br />

<strong>Multifetal</strong> <strong>Pregnancies</strong>:<br />

<strong>Its</strong> More than Chorionicity”<br />

Anthony Johnson, DO<br />

Professor, UTHSC, Houston, TX<br />

Co-Director, Texas Fetal Center, CMHH<br />

1


Disclosures<br />

• I have no relationships with commercial companies<br />

that could be perceived as a conflict of <strong>in</strong>terest.<br />

• I will not be discuss<strong>in</strong>g the use of products that are<br />

<strong>in</strong>vestigational or approved devices that are be<strong>in</strong>g<br />

used “off label”


Per<strong>in</strong>atal mortality<br />

MC vs. DC tw<strong>in</strong>s<br />

Dutch cohort study 1995-2004<br />

Outcome<br />

Per<strong>in</strong>atal<br />

Mortality<br />

MC<br />

(n = 198)<br />

DC<br />

(1107)<br />

Hazard Risk<br />

(95%CI)<br />

11.6% 5.0% 2.44<br />

(1.73-3.44)<br />

Stillbirth 7.6% 1.5% 5.21<br />

(3.18-8.51)<br />

Screen<strong>in</strong>g protocol:<br />

- 1 st trimester ultrasound for chorionicity<br />

- 20 wks anatomic survey<br />

- Serial ultrasounds (fortnightly) for growth, AFV and Doppler assessment<br />

Hack KEA et al BJOG 2008;115:58-67


Outcome of MCDA tw<strong>in</strong> gestations <strong>in</strong> the<br />

era of <strong>in</strong>vasive fetal therapy<br />

Survival<br />

Tw<strong>in</strong> live births 172 85%<br />

S<strong>in</strong>gleton 15 7%<br />

Double demise 15 7%<br />

Complication<br />

TTTS 18 9%<br />

sIUGR 30 15%<br />

Losses<br />

Total 11% (TTTS ~ 42%)<br />

< 24 weeks 84%<br />

> 24 weeks 16%<br />

> 32 weeks 1%<br />

Extra loss <strong>in</strong> MC tw<strong>in</strong>s is due to complications placental anastomoses<br />

Lewi et al., 2008


Complications <strong>in</strong> Monochorionic<br />

Multi-Fetal <strong>Pregnancies</strong><br />

• Tw<strong>in</strong>-Tw<strong>in</strong> Transfusion Syndrome<br />

- Oligo/Polyhydramnios Sequence ~ TOPS<br />

- Tw<strong>in</strong> Anemia Polycythemia Sequence ~ TAPS<br />

• Tw<strong>in</strong> Reverse Arterial Perfusion<br />

• Growth Discordance<br />

• Discordant malformations<br />

- Structural<br />

- Chromosomal<br />

• Monoamnioitc


Diagnosis


"There is NO diagnosis of tw<strong>in</strong>s.”<br />

“The only diagnosis is a monochorionic or<br />

dichorionic tw<strong>in</strong> gestation.<br />

This should be written <strong>in</strong> capital red letters<br />

on the front of the chart at 8 - 10 weeks".<br />

K Nicolaides, 02/27/09


<strong>Multifetal</strong> <strong>Pregnancies</strong><br />

<strong>Ultrasound</strong> Determ<strong>in</strong>ation of<br />

Amnionicity & Chorionicity<br />

1 st Trimester <strong>Ultrasound</strong> Exam<strong>in</strong>ation:<br />

- Amnionicity and chorionicity should be documented for all<br />

multiple gestations when possible.<br />

2 nd & 3 rd Trimester <strong>Ultrasound</strong> Exam<strong>in</strong>ation:<br />

- Multiple gestations require the documentation of additional<br />

<strong>in</strong>formation: chorionicity, amnionicity, comparison of fetal<br />

sizes, estimation of amniotic fluid volume on each side of<br />

the membrane, and fetal genitalia (when visualized).<br />

AIUM PRACTICE GUIDELINES, Oct 2007<br />

ACOG PRACTICE GUIDELINES, #101, Reaffirmed 2011


<strong>Ultrasound</strong> techniques for determ<strong>in</strong><strong>in</strong>g<br />

chorionicity & amnionicity<br />

Umbilical cord entanglement<br />

Fetal sex<br />

Separate placental discs<br />

No. of layers <strong>in</strong> membrane<br />

Membrane thickness<br />

Lambda or Tw<strong>in</strong> Peaks or T-sign<br />

No. of yolk sacs<br />

No. of gestational sacs<br />

amnionicity<br />

chorionicity<br />

First trimester Second Trimester Third Trimester<br />

J Rob<strong>in</strong>son & AZ Abuhamad Modern Medic<strong>in</strong>e 2002


<strong>Multifetal</strong> <strong>Pregnancies</strong><br />

Chorionicity<br />

Monochorionic<br />

“T” sign<br />

Dichorionic<br />

Lambda or Tw<strong>in</strong> Peak sign<br />

Moise KJ Texas Medic<strong>in</strong>e 2007


<strong>Multifetal</strong> <strong>Pregnancies</strong> ~ Establish chorionicity<br />

10 - 14 weeks<br />

“T” sign<br />

Monochorionic<br />

Tw<strong>in</strong> Peak (lambda)<br />

Dichorionic


Accuracy of Ultrasonographic<br />

Chorionicity Classification*<br />

Pathologic Evaluation<br />

Misclassification<br />

Total 545 6.4%<br />

Dichorionic 455 4%<br />

Monochorionic 90 19%<br />

*Classified by ultrasound < 20 weeks<br />

Sensitivity Specificity PPV NPV<br />

96% 81% 96% 80%<br />

< 14 wks vs. 15-20 wks<br />

Odds Ratio: 0.47; 95% CI 0.23, 0.96<br />

58% ACOG optimal time for Dx chorionicity 1 st trimester<br />

62% Manage all tw<strong>in</strong>s without MFM consultation<br />

Blumenfeld Y AIUM 2013; Cleary-Goldman J et al 2004


Accuracy of referral vs. tertiary diagnosis of<br />

amnionicity and chorionicity<br />

Tw<strong>in</strong>s<br />

DADC<br />

DAMC<br />

MOMO<br />

Triplets<br />

TATC<br />

TADC<br />

TAMC<br />

Center DADC DAMC MOMO Total<br />

Referr<strong>in</strong>g<br />

Tertiary<br />

Referr<strong>in</strong>g<br />

Tertiary<br />

Referr<strong>in</strong>g<br />

Tertiary<br />

Referr<strong>in</strong>g<br />

Tertiary<br />

Referr<strong>in</strong>g<br />

Tertiary<br />

Referr<strong>in</strong>g<br />

Tertiary<br />

45%<br />

98%<br />

28%<br />

96%<br />

49%<br />

96%<br />

24%<br />

92%<br />

50%<br />

83%<br />

0<br />

100%<br />

83<br />

167<br />

40<br />

72<br />

8<br />

5<br />

8<br />

25<br />

4<br />

13<br />

1<br />

1<br />

Accurate diagnosis of A/C can be obta<strong>in</strong>ed by assessment of key sonographic f<strong>in</strong>d<strong>in</strong>gs<br />

Emphasis on need to enhance diagnostic skills <strong>in</strong> the general community & referral if dx ambiguous<br />

Wan JJ et al Prenat Diagn 2011


Take home message<br />

Two is better than one !!


Bipartite Monochorionic<br />

Placentation<br />

• Tw<strong>in</strong> <strong>Pregnancies</strong> with two<br />

separate placental masses can<br />

still be monochorionic and have<br />

vascular anastomoses<br />

• Lopriore E, et al 2006 ~ 3/109<br />

• Mach<strong>in</strong> GA et al 2002 ~ 8/600<br />

If is looks like TTTS ~ it is until proven otherwise


Monozygotic Tw<strong>in</strong>s<br />

Incidence of Anomalies<br />

– 845 pairs of tw<strong>in</strong>s w/evaluation of zygosity:<br />

• 483 monozygotic<br />

• 252 dizygotic<br />

• 110 zygosity unconfirmed<br />

– Anomalies:<br />

• MZ: 2.7% (82% discordant)<br />

• DZ: 1% (100% discordant)<br />

• S<strong>in</strong>gletons: 0.6%<br />

Chen et al. Acta Genet Med Gememol 1992;41:197-203


Bahityar MO, J <strong>Ultrasound</strong> Med 2007;26:1491


Monochorionic Tw<strong>in</strong>s<br />

Management of Anomalies<br />

Risk of death or longterm compromise co-tw<strong>in</strong><br />

• Old theory of “bad humors’ cross<strong>in</strong>g to the live tw<strong>in</strong><br />

discounted<br />

• Acute hemodynamic changes the more likely etiology<br />

• No benefit from acute delivery<br />

• 15% of cases associated with IUFD of co-tw<strong>in</strong><br />

– ↑ 5X over dichorionic tw<strong>in</strong>s<br />

• 34% abnormal postnatal cranial imag<strong>in</strong>e with IUFD co-tw<strong>in</strong><br />

• 26% of survivors with neurologic sequelae<br />

– ↑ 12X over dichorionic tw<strong>in</strong>s<br />

Fusi et al. Obstet Gynecol 1991;78:517-20<br />

Ong et al. BJOG 2006;113:992-8<br />

Hillman et al Obstet Gynecol 2011;118:928-40


Maternal-Fetal Surgery: Balanc<strong>in</strong>g Risks<br />

Discordant Fetal Malformation<br />

<strong>Multifetal</strong> Gestations<br />

Observation<br />

Intervention


Per<strong>in</strong>atal Outcomes of Tw<strong>in</strong> <strong>Pregnancies</strong><br />

Discordant for Major Fetal Anomalies<br />

Category Normal Tw<strong>in</strong>s Discordant<br />

Tw<strong>in</strong>s*<br />

Number 235 13<br />

GA_Delivery 34<br />

(16-40)<br />

Birth Weight 2030<br />

(180 – 3680)<br />

Per<strong>in</strong>atal<br />

Survival<br />

*2/3 cotw<strong>in</strong> <strong>in</strong> MCDA set end as IUFD<br />

32<br />

(24-37)<br />

1640<br />

(520-3320)<br />

P<br />

0.029<br />

0.022<br />

91% 69% 0.018<br />

Gul A et al, Fetal Diagno Ther 2005;20:244


Dilemmas <strong>in</strong> Management of tw<strong>in</strong>s discordant<br />

for anencephaly diagnosed at 11-14 weeks<br />

Chorionicity # Hydramnios Livebirth GA<br />

Delivery<br />

Delivery<br />

< 33 wks<br />

DICHORIONIC<br />

Expectant Obs<br />

Reduction<br />

35<br />

9<br />

57%<br />

0<br />

97%<br />

89%<br />

36<br />

37<br />

18%<br />

13%<br />

Monochorionic<br />

Expectant Obs 19 52% 84%* 33 38%<br />

MC Intervention<br />

Laser coagulation<br />

Cord Ligation<br />

Bipolar<br />

6<br />

24<br />

92<br />

100%<br />

54%<br />

77%<br />

33%<br />

69%<br />

31%<br />

* IUFD of affected Tw<strong>in</strong> with co-tw<strong>in</strong> demise <strong>in</strong> 3/4<br />

Vandecruys H <strong>Ultrasound</strong> Obstet Gynecol 2006;28:653


Acardiac Tw<strong>in</strong><br />

Incidence 1/35,000<br />

Earliest form of TTTS<br />

Reverse Arterial Perfusion ~‘acardiac”<br />

Co-tw<strong>in</strong> anomaly ~ 10%<br />

Per<strong>in</strong>atal M&M ~ 50%<br />

Growth AT:PUMP 70%<br />

Polyhydramnios<br />

Cardiac decompensation <strong>in</strong> pump tw<strong>in</strong>


Acardiac Tw<strong>in</strong>


Acardiac Tw<strong>in</strong>


Outcome <strong>in</strong> TRAP <strong>Pregnancies</strong><br />

Observation vs. Intervention<br />

Acardiac size < 50% of Pump<br />

Group N Acardiac<br />

Size<br />

MOMO<br />

Pump<br />

Survival<br />

GA<br />

Delivery<br />

Observation 8 27% 38% 88% 34<br />

Intervention<br />

(RFA)<br />

7 49% 0% 100% 36<br />

Jel<strong>in</strong> E et al Fetal Diagn Therp 2010:27;138


Outcome of TRAP sequence diagnosed <strong>in</strong> the<br />

IUFD of<br />

pump tw<strong>in</strong>, 33%<br />

first trimester<br />

Survival Rate<br />

1 st Tri DX<br />

46% 11/24<br />

Arrest of Flow<br />

Acardiac, 24%<br />

3/5 Pump tw<strong>in</strong>s<br />

Demise or Abnl CNS<br />

Follow<strong>in</strong>g arrest<br />

of flow to acardiac<br />

Pump alive Flow<br />

In Acardiac, 46%<br />

Intervention need<br />

12-16 weeks<br />

Liesbeth L et al, AJOG, 2010; 203,213.e1 - 213.e4


Tw<strong>in</strong>-tw<strong>in</strong><br />

Transfusion<br />

Syndrome


Monochorionic Tw<strong>in</strong>s<br />

Epidemiology of TTTS<br />

• Complicates 9 – 15% of MCDA tw<strong>in</strong>s<br />

• 1 <strong>in</strong> 58 tw<strong>in</strong> pregnancies<br />

• 1 <strong>in</strong> 4,170 pregnancies<br />

• Presentation < 26 weeks ~ 90% per<strong>in</strong>atal mortality<br />

Dick<strong>in</strong>son et al. Am J Obstet Gynecol 2000;182:706-12<br />

Saunders et al. Am J Obstet Gynecol 1992;166:820-4


Tw<strong>in</strong> Tw<strong>in</strong> Transfusion<br />

Syndrome Diagnosis<br />

S<strong>in</strong>gle placenta<br />

Polyhydramnios (8cm) / oligohydramnios (2cm)<br />

Concordant for sex<br />

Discordant for size and placental echogenicity<br />

Recipient persistent enlarged bladder<br />

Donor small or non-visible bladder


Prediction of Tw<strong>in</strong> Tw<strong>in</strong> Transfusion<br />

Nuchal Translucency<br />

Fold<strong>in</strong>g Intertw<strong>in</strong> Membrane<br />

Arterio-arterial anastomoses<br />

Discordant AFV*<br />

*Sueters M et al <strong>Ultrasound</strong> Obstet Gynecol. 2006 Oct;28(5):659-64


Tw<strong>in</strong>-Tw<strong>in</strong> Transfusion Syndrome Stag<strong>in</strong>g<br />

(TOPS)<br />

Stage I<br />

Stage II<br />

Stage III<br />

Stage IV<br />

Oligohydramnios(8cm)<br />

Discordant fluid volume<br />

No bladder <strong>in</strong> the donor tw<strong>in</strong><br />

Doppler flow- absent or reversed <strong>in</strong> umbilical artery or<br />

ductus venosus, pulsatile flow <strong>in</strong> the umbilical ve<strong>in</strong><br />

Hydrops <strong>in</strong> one or both fetuses<br />

Stage V<br />

One or both fetuses have died<br />

Qu<strong>in</strong>tero R et al J. Per<strong>in</strong>atol 1999;19:55


Qu<strong>in</strong>tero Stage Related Outcomes <strong>in</strong> TTT<br />

Follow<strong>in</strong>g Laser Photocoagulation<br />

Report N I II III IV<br />

Qu<strong>in</strong>tero, 2003<br />

Both<br />

95<br />

67%<br />

49%<br />

25%<br />

46%<br />

> 1<br />

86%<br />

86%<br />

79%<br />

82%<br />

Huber, 2006<br />

Both<br />

200<br />

76%<br />

61%<br />

54%<br />

50%<br />

> 1<br />

93%<br />

83%<br />

83%<br />

70%


Suspected TTTS<br />

How often Dx Correct & Referral Timely<br />

N %<br />

Confirmed Dx TTTS 249 77%<br />

Stage<br />

1<br />

2<br />

3<br />

4<br />

5<br />

28<br />

50<br />

150<br />

15<br />

10<br />

11%<br />

20%<br />

60%<br />

6%<br />

4%<br />

No TTTS 75 23%<br />

Discordant AFV<br />

sIUGR<br />

42<br />

33<br />

56%<br />

44%<br />

Gandhi M et al, 2012


Tw<strong>in</strong> Anemia-Polycythemia Sequence<br />

(TAPS)<br />

• Larger <strong>in</strong>tertw<strong>in</strong> hemoglob<strong>in</strong> difference w/o signs of<br />

TOPS<br />

• Intertw<strong>in</strong> blood transfusion w/o hormonal<br />

imbalance<br />

• Post laser: ex-recipient anemic w/ ex-donor<br />

polycythemic ~ 77%<br />

• Spontaneous reported as early as 16 weeks<br />

Study N Post-laser<br />

Robyr, 2006 101 13%<br />

Habli, 2009 152 2%<br />

Slagehekke,2010 276 8%<br />

Spontaneous*<br />

Lewi et al, 2009 202 5%<br />

Lopriore, 2010 113 5%<br />

Slagehekke F et al Fetal Diagn Therapy 2010


TAPS<br />

Optimal Management is Unclear<br />

• Expectant observation<br />

• Induction of labor<br />

• Selective reduction<br />

• Laser photocoagulation<br />

• Intrauter<strong>in</strong>e transfusion<br />

Intravascular/<strong>in</strong>traperitoneal<br />

IV / exchange transfusion<br />

• Per<strong>in</strong>atal mortality and<br />

morbidity unknown<br />

• Majority Dual Survivors<br />

• IUFD (dual & s<strong>in</strong>gle)<br />

• Thrombosis, CNS<br />

Infarct; Hydrops<br />

Delivery 32 wks 4 days<br />

Dual survivors<br />

S<strong>in</strong>gle AA at placental edge<br />

Herway C et al <strong>Ultrasound</strong> Obstet Gynecol 2009;33:592


Vascular Occlusion Injuries <strong>in</strong> TTTS<br />

• 95% recipient<br />

• 85% lower limb<br />

• 71% right sided<br />

• Intest<strong>in</strong>al atresia<br />

• Mechanism<br />

• Polycythemia<br />

• Hyperviscosity<br />

• Hypertension<br />

• Vascoconstriction<br />

Schrey S et al AJOG 2012


Discordant Growth & Selective IUGR


Discordant Growth <strong>in</strong> Tw<strong>in</strong> <strong>Pregnancies</strong><br />

Associated Outcomes<br />

• Anomalies<br />

• IUGR<br />

• Preterm Birth<br />

• Intrauter<strong>in</strong>e <strong>in</strong>fection<br />

• Stillbirth<br />

• UA cord ph < 7.10<br />

• NICU Admission<br />

• RDS<br />

• Neonatal Death<br />

Debate<br />

• Detection efficacy<br />

• Significant threshold<br />

• Co-morbidities<br />

• Management strategy<br />

ACOG Practice Bullet<strong>in</strong> #56, reaffirmed 2009


Factors Affect<strong>in</strong>g Fetal<br />

Maternal<br />

Placental*<br />

Fetal<br />

Growth Discordance<br />

• Tobacco<br />

• Vascular disease<br />

• Poor prenatal care<br />

• Low Maternal wt ga<strong>in</strong><br />

• Vascular anastomoses<br />

• Placental shar<strong>in</strong>g<br />

• Placental weight<br />

• Velamentous <strong>in</strong>sertion<br />

• Aneuploidy<br />

• Sex-discordance<br />

• Viral Infection<br />

* Major component of discordance <strong>in</strong> MC tw<strong>in</strong>n<strong>in</strong>g


Def<strong>in</strong>ition & Impact of Discordant<br />

Fetal Growth <strong>in</strong> MC Tw<strong>in</strong>s<br />

Discordant growth = selective growth restriction<br />

• Discordant Growth<br />

- (Largest – Smallest) / Largest * 100<br />

- EFW or birthweight<br />

- ACOG def<strong>in</strong>es discordance 15-25%<br />

- SOGC – > 20% EFW or [AC large – AC small] > 20 mm<br />

31 publications > 1.1 million tw<strong>in</strong>s<br />

16% discordance<br />

137,000 US tw<strong>in</strong> births/yr<br />

22,000 discordant tw<strong>in</strong>s/yr<br />

Mart<strong>in</strong> JA CDC NCHS data brief 80;2012<br />

Miller J et al AJOG 2012:206;10


First trimester prediction<br />

Tw<strong>in</strong> complications & adverse outcome<br />

Study # Placenta Bwt<br />

> 20%<br />

sIUGR<br />

Early<br />

IUFD<br />

Per<strong>in</strong>atal<br />

Mortality<br />

Sebire, 1998 549 MC/DC - - + -<br />

Kalish, 2004 159 DC + - + -<br />

Tai, 2007 178 MC/DC + - - -<br />

Banks, 2008 135 DC - - - -<br />

Memmo, 2011 242 MC +<br />

D’Antonio, 2013 2155 MC/DC - - - -<br />

In the absence of aneuploidy or structural malformations CRL discordance<br />

is a poor predictor for adverse per<strong>in</strong>atal outcome <strong>in</strong> MC and DC tw<strong>in</strong> pregnancies<br />

D’Antonio F, <strong>Ultrasound</strong> Obstet Gynecol.2013; Feb 14. doi: 10.1002/uog.12430


Discordant Growth <strong>in</strong> Tw<strong>in</strong> <strong>Pregnancies</strong><br />

2 nd Trimester <strong>Ultrasound</strong> Predictive Accuracy<br />

Discordance > 20%<br />

Screen<strong>in</strong>g Test Sensitivity Specificity<br />

AC 65-83% 65-90%<br />

EFW 50-93% 80-93%<br />

Miller J et al AJOG. 2012;206:10-20


Discordance & Adverse Outcome by Chorionicity<br />

DC 18% discordance =<br />

Uncomplicated MC<br />

MC 18% discordance<br />

double risk of adverse outcome<br />

SGA 5%<br />

18% BW<br />

Discordance<br />

Choriionicity HR (95% CI) P HR (95% CI) P<br />

Monochorionic 2.6 (1.4-4.7)


Cl<strong>in</strong>ical<br />

MCDA Discordant Growth*<br />

Early<br />

(15)<br />

Late<br />

(13)<br />

Discordance EFW > 20% < 20 wks > 26 wks<br />

Concordant<br />

(150)<br />

UA Doppler abnl 73% 0 3%<br />

IUFD 27% 8% 1%<br />

TAPS 0 38% 3%<br />

GA_Delivery 33 35 35<br />

Birthwt discordance 30% 31% 9%<br />

Overall Survival Rate 83% 96% 99%<br />

Placenta<br />

Placenta Territory ratio 2.55 1.6 1.4<br />

Total Anastomotic<br />

Diameter (mm)<br />

* Bwt Discordance > 25%<br />

14 6 9<br />

Lewi L AJOG 2008;199:511.e1


Monochorionic Tw<strong>in</strong>s<br />

Selective IUGR<br />

• 10-15% of monochorionic tw<strong>in</strong>s<br />

• Smaller tw<strong>in</strong> EFW < 10%tile for gestational age<br />

• Unequal placental shar<strong>in</strong>g<br />

• +/- Unbalanced <strong>in</strong>tertw<strong>in</strong> vascular flow<br />

• Per<strong>in</strong>atal mortality & long term morbidity<br />

- Smaller tw<strong>in</strong>: IUFD 30-40% Neurologic 15-40%<br />

- Cotw<strong>in</strong> tw<strong>in</strong>: IUFD 25-30% Neurologic 20-30%<br />

- iatrogenic prematurity<br />

- acute feto-feto transfusion


Monochorionic Tw<strong>in</strong>s<br />

Classification sIUGR<br />

Type<br />

Umbilical<br />

Artery<br />

IUFD<br />

Neurologic<br />

Compromise<br />

In Utero<br />

Deterioration<br />

GA<br />

Delivery<br />

I Normal 2-4%


Per<strong>in</strong>atal outcome with expectant observation <strong>in</strong><br />

sIUGR by Umbilical Artery Doppler Classification<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

96%<br />

2%<br />

2%<br />

33%<br />

26%<br />

41%<br />

38%<br />

23%<br />

38%<br />

Intact<br />

Survivors<br />

Both<br />

One<br />

None<br />

Type I Type II Type III<br />

(23) (27) (13)<br />

Ishii K et al Fetal Diagn Ther 2009;26:157


Monochorionic Tw<strong>in</strong>s<br />

Selective IUGR<br />

Expectant Observation<br />

• Fetal monitor<strong>in</strong>g<br />

- Biophysical profile<br />

- Ductus venosus Doppler blood flow studies <strong>in</strong> Type II<br />

• Early delivery<br />

• Selective reduction<br />

• Laser ablation placental anastomoses ~ RCT


Monochorionic Diamniotic Tw<strong>in</strong>s<br />

Frequency of <strong>Ultrasound</strong> Evaluations<br />

• Serial sonographic evaluations every 2 weeks, beg<strong>in</strong>n<strong>in</strong>g at<br />

16 weeks, until delivery, should be considered for all tw<strong>in</strong>s<br />

with MCDA placentation<br />

• Screen<strong>in</strong>g for congenital heart disease is warranted <strong>in</strong> all<br />

MC tw<strong>in</strong>s, <strong>in</strong> particular those complicated with TTTS<br />

SMFM Committee Op<strong>in</strong>ion<br />

Am J Obstet Gynecol. 2013;208(1):3-18


Two Step Screen<strong>in</strong>g Strategy for<br />

Complicated Outcomes <strong>in</strong> MC Tw<strong>in</strong>s<br />

Lewi L et al Am J Obstet Gynecol 2008;199:511.e1-7


Tw<strong>in</strong>s <strong>Ultrasound</strong> Surveillance<br />

All tw<strong>in</strong>s<br />

- <strong>Ultrasound</strong> for anomalies at 18 – 20 weeks<br />

- Placental Cord Insertions<br />

- Weekly Biophysical profile > 32 weeks<br />

Dichorionic<br />

- <strong>Ultrasound</strong>s Q 4 weeks for serial growth<br />

- Change <strong>in</strong> AFV and Doppler UA may precede discordant growth<br />

Monochorionic tw<strong>in</strong>s<br />

- <strong>Ultrasound</strong>s alternate limited and growth, Q 2 weeks, 16 wks<br />

- Amniotic fluid volume, bladder<br />

- Fetal growth<br />

- Doppler blood flow studies<br />

- UA, UV, DV and MCA basel<strong>in</strong>e 20 weeks<br />

- Repeat if > 20% discordance with smaller < 10%<br />

- Uncomplicated or late discordance MCA<br />

- Fetal echocardiography


Conclusion<br />

Increase awareness of risks associated with MC pregnancies by<br />

healthcare providers and patients<br />

– “No Dx Tw<strong>in</strong>s”<br />

• Establish chorionicity early<br />

• Risk stratify multifetal pregnancies DC vs. MC<br />

– MC pregnancies serial ultrasound beg<strong>in</strong>n<strong>in</strong>g at 16 weeks<br />

• Limited (MVP, UA and bladder)<br />

• Growth studies with Doppler assessment<br />

– MFM/Fetal Treatment Center referral consultation for<br />

• Targeted ultrasound/echo<br />

• Signs of discordance growth or AFV<br />

Update ACOG Practice Bullet<strong>in</strong> #56 October, Multiple Gestation:<br />

Complicated Tw<strong>in</strong>s, Triplets and High-Order <strong>Multifetal</strong> Pregnancy<br />

5<br />

3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!